OUP Management Company’s Vor Biopharma VOR Stock Holding History

OUP Management Company’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$794K	Hold	18,736	–	–	1.79%	7
2023 Q2	$1.16M	Hold	18,736	–	–	1.97%	6
2023 Q1	$2.02M	Hold	18,736	–	–	4.02%	7
2022 Q4	$2.49M	Hold	18,736	–	–	4.07%	7
2022 Q3	$1.49M	Hold	18,736	–	–	2.32%	7
2022 Q2	$1.86M	Hold	18,736	–	–	2.56%	8
2022 Q1	$2.26M	Hold	18,736	–	–	1.72%	11
2021 Q4	$4.35M	Buy	+18,736	New	+$5.4M	1.96%	13

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

OUP Management Company's VOR Position: Q3 2023 in Review

OUP Management Company held its Vor Biopharma (VOR) position steady in Q3 2023 at 18,736 shares worth $794K. The position accounts for 1.79% of the portfolio, ranked #7.

OUP Management Company first reported a position in VOR in Q4 2021 and has held it in 8 quarters since. The position peaked at $4.35M in Q4 2021. 59 funds tracked by Wall St. Rank hold VOR as of Q3 2023.

OUP Management Company held 18,736 shares of Vor Biopharma worth $794K as of Q3 2023.
OUP Management Company left its Vor Biopharma share count unchanged in Q3 2023.
Vor Biopharma made up 1.79% of OUP Management Company's portfolio in Q3 2023, its #7 holding.
OUP Management Company first reported a position in Vor Biopharma in Q4 2021 and has held it in 8 quarters since.
OUP Management Company's Vor Biopharma position peaked at $4.35M in Q4 2021.
59 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2023.

Based on OUP Management Company's 13F filing for Q3 2023, filed 9 Nov 2023.